spec sheet7 rows
Bamaluzole is an experimental anticonvulsant from the imidazopyridine chemical class, patented by Merck as a potential seizure treatment but never marketed.
- Patented as a candidate anticonvulsant that enhances GABA-A receptor activity
Overview
A shelved Merck anticonvulsant candidate; works on GABA-A receptors like many seizure and anxiety drugs, but never got past the patent stage.
Mechanism
Bamaluzole acts as an at the -A receptor, the -gated chloride channel responsible for most fast inhibitory signaling in the brain. By enhancing GABA-A receptor activity, it increases chloride ion influx into neurons, causing hyperpolarization (a reduced likelihood of firing) that dampens the runaway neuronal excitability underlying seizures. It belongs to the imidazopyridine chemical class.
receptor fingerprint
-A receptorAgonist
Safetyrisks and cautions, not medical advice
No published clinical safety or tolerability data exists. Bamaluzole was patented as a seizure-prevention agent but was never advanced to marketed use, and detailed toxicology has not been made public.
Subjective profileweighing the evidence above
A patent and a mechanism, nothing else. No published human safety data, no public toxicology, never marketed anywhere, so there is nothing here to weigh. Anyone who actually needs an anticonvulsant has a long list of properly studied options.
Resources
This entry is here for reference.
Reviews
My notesprivate to this device
FAQ
What is Bamaluzole used for?
Nothing today. It was a Merck-patented anticonvulsant candidate that never reached the market or, as far as public records show, human trials.
How does Bamaluzole work?
It acts on GABA-A receptors, the same inhibitory brain receptors targeted by benzodiazepines and barbiturates, increasing chloride flow into neurons to calm excessive electrical activity linked to seizures.
Is Bamaluzole well-researched?
No. Information is limited to its patent record and chemical classification; no substantial published pharmacology or clinical research exists.
Limitations of the evidence
- No published human safety data exists
- Never marketed or approved anywhere
- Detailed toxicology was never made public